Recent publications by Researchers affiliated with the Centre for Tropical Medicine and Global Health
Field evaluation of the diagnostic performance of EasyScan GO: a digital malaria microscopy device based on machine-learning
Das D. et al, (2022), Malaria Journal, 21
Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?
van der Pluijm RW. et al, (2022), The Lancet Infectious Diseases, 22, 765 - 766
Triple therapy with artemether–lumefantrine plus amodiaquine versus artemether–lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial
Peto TJ. et al, (2022), The Lancet Infectious Diseases, 22, 867 - 878
Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-umefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial (vol 22, pg 867, 2022)
Peto TJ. et al, (2022), LANCET INFECTIOUS DISEASES, 22, E128 - E128
Defining the burden of febrile illness in rural South and Southeast Asia: an open letter to announce the launch of the Rural Febrile Illness project
Chandna A. et al, (2022), Wellcome Open Research, 6, 64 - 64
Acceptability and feasibility of malaria prophylaxis for forest goers: findings from a qualitative study in Cambodia
Jongdeepaisal M. et al, (2021), Malaria Journal, 20
Evolution of Multidrug Resistance in Plasmodium falciparum: a Longitudinal Study of Genetic Resistance Markers in the Greater Mekong Subregion
Imwong M. et al, (2021), Antimicrobial Agents and Chemotherapy, 65
Good participatory practice for coronavirus disease 2019 (COVID-19) research: the case of a COVID-19 prevention study
Perrone C. et al, (2021), Wellcome Open Research, 6, 216 - 216
Genetic surveillance in the Greater Mekong subregion and South Asia to support malaria control and elimination
Jacob CG. et al, (2021), eLife, 10
Study protocol: an open-label individually randomised controlled trial to assess the efficacy of artemether-lumefantrine prophylaxis for malaria among forest goers in Cambodia
Maude RJ. et al, (2021), BMJ Open, 11, e045900 - e045900
Theory of change: Drama and arts-based community engagement for malaria research and elimination in Cambodia
Ean M. et al, (2021), Wellcome Open Research, 6, 46 - 46
The WHO guideline on drugs to prevent COVID-19: small numbers- big conclusions
Schilling WHK. et al, (2021), Wellcome Open Research, 6, 71 - 71
Defining the burden of febrile illness in rural South and Southeast Asia: an open letter to announce the launch of the Rural Febrile Illness project
Chandna A. et al, (2021), Wellcome Open Research, 6, 64 - 64
Theory of change: Drama and arts-based community engagement for malaria research and elimination in Cambodia
Ean M. et al, (2021), Wellcome Open Research, 6, 46 - 46
Engaging ethnic minority communities through performance and arts: health education in Cambodian forest villages
Callery JJ. et al, (2021), International Health, 13, 188 - 195
The WHO guideline on drugs to prevent COVID-19: small numbers- big conclusions.
Schilling WH. et al, (2021), Wellcome open research, 6
Theory of change: Drama and arts-based community engagement for malaria research and elimination in Cambodia.
Ean M. et al, (2021), Wellcome open research, 6
Tools to accelerate falciparum malaria elimination in Cambodia: a meeting report
Lek D. et al, (2020), Malaria Journal, 19
Chloroquine/ hydroxychloroquine prevention of coronavirus disease (COVID-19) in the healthcare setting; protocol for a randomised, placebo-controlled prophylaxis study (COPCOV)
Schilling WHK. et al, (2020), Wellcome Open Research, 5, 241 - 241